Ying Xu, Luxi Cao, Wenli Zou, Rizhen Yu, & Wei Shen. (2023). Panax notoginseng saponins inhibits NLRP3 inflammasome-mediated pyroptosis by downregulating lncRNA-ANRIL in cardiorenal syndrome type 4. BMC.
Chicago Style (17th ed.) CitationYing Xu, Luxi Cao, Wenli Zou, Rizhen Yu, and Wei Shen. Panax Notoginseng Saponins Inhibits NLRP3 Inflammasome-mediated Pyroptosis by Downregulating LncRNA-ANRIL in Cardiorenal Syndrome Type 4. BMC, 2023.
MLA (9th ed.) CitationYing Xu, et al. Panax Notoginseng Saponins Inhibits NLRP3 Inflammasome-mediated Pyroptosis by Downregulating LncRNA-ANRIL in Cardiorenal Syndrome Type 4. BMC, 2023.
Warning: These citations may not always be 100% accurate.